Covid 19 – We would like to reassure our customers that our services remain operational during this time. We are taking calls 8am-8pm 7 days a week.
Articles by Kate Sneddon
Since the late 1980s, umbilical cord blood and related birthing tissues have evolved from medical waste to a rich source of blood stem cells. These can be transplanted to restore normal blood and immune cell development and function in blood diseases such as leukemia and lymphoma, certain inherited genetic disorders, bone marrow failure and immune deficiency diseases.
There is very little scientific evidence for the value of banking placenta cells clinically. Biovault is always excited about developments in tissue and cell banking and we keep a close eye on innovation within our Industry. However, in line with our ethical and cautious approach, fostered through our long working relationship with the NHS we […]
Since the inception of umbilical cord blood stem cell cryopreservation in the 1990s, the number of public and privately banked units worldwide has grown to more than 800,0001 and 7 million2 respectively. This new field of medicine has blossomed since the world’s first cord blood transplant took place in 1988, using sibling donor stem […]
Stem cell donation is vital Toddler Arlo Brown was diagnosed with the rare blood cancer myelomonocytic leukaemia in April. Seriously ill, he underwent a stem cell transplant in August. He is still very poorly but according to recent newspaper reports, is showing signs of recovery, although he relies on regular blood transfusions and a tube […]
Research suggests that COVID-19 is not present in birthing tissues collected at the time of birth. Welcome to our Friday update where we have news from the recent 2020 Cord Blood Connect attended by Biovault Family’s CEO Kate Sneddon. Usually an annual conference held in Miami, this year’s event moved to a virtual platform allowing […]
Cord blood transplants provide an opportunity for a cure from blood cancer with siblings offering the best chance of finding a match September marks Blood Cancer Awareness Month. Every year, more than 2,000 people in the UK with a blood cancer or blood disorder are in need of a potentially lifesaving blood stem cell donation […]
Congratulations on the imminent birth of your second child. How are you all? Thank you. We are all well and a great mix of excited, nervous and curious all in one while we wait for the arrival of the next addition to our household. This time around it is a little girl, so Alexander has a […]
Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Maintains and Partially Improves Visual Function in Patients with Advanced Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a hereditary retinal degeneration disease with no effective therapeutic approaches. Inflammatory and immune disorders are thought to play an important role in the pathogenesis of RP. Human umbilical cord mesenchymal stem cells (UCMSCs), with multiple biological functions such as anti-inflammation and immunoregulation, have been applied in different systemic diseases. We conducted […]